Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Filana Therapeutics, Inc. FLNA

Full chart Compare
Set alert

Price alert · FLNA

All alert types
0.59 USD +0.03 (+5.94%)

At closeNov 3, 2026, 4:02 PM EST

0.59 0.00 0.00%

After hours · Nov 3, 4:02 PM ET

0.56 Day range 0.5999
0.56 52-week range 3.45
YTD
-69.98%
1 year
-81.37%

Financial health

Altman Z-Score

-7.38 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -1.1×
FY 2016: -0.9×FY 2017: -1.1×FY 2018: -3.4×FY 2019: -7.6×FY 2020: -8.5×FY 2021: -2.5×FY 2022: -1.1×FY 2023: -0.9×FY 2024: -3.9×FY 2025: -1.1×
FY 2016 5y median -1.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.3×
FY 2016: 0.7×FY 2017: 1.4×FY 2018: 1.1×FY 2019: 1.6×FY 2020: 0.6×FY 2021: 0.3×FY 2022: 0.4×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 1.3×
FY 2016 5y median 0.6× FY 2025
P/FCF -3.0×
FY 2016: -1.1×FY 2017: -1.6×FY 2018: -4.6×FY 2019: -14.1×FY 2020: -9.9×FY 2021: -1.5×FY 2022: -1.0×FY 2023: -1.0×FY 2024: -0.8×FY 2025: -3.0×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -0.0×
FY 2016: 0.2×FY 2017: -0.2×FY 2018: -0.3×FY 2019: -1.3×FY 2020: 3.6×FY 2021: 4.8×FY 2022: 1.5×FY 2023: 0.3×FY 2024: 0.2×FY 2025: -0.0×
FY 2016 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -33.2%
FY 2016: -92.1%FY 2017: -61.5%FY 2018: -21.8%FY 2019: -7.1%FY 2020: -10.1%FY 2021: -64.9%FY 2022: -97.3%FY 2023: -95.9%FY 2024: -123.2%FY 2025: -33.2%
FY 2016 5y median -95.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -122.3%
FY 2016: -79.7%FY 2017: -122.8%FY 2018: -33.4%FY 2019: -21.0%FY 2020: -6.9%FY 2021: -12.8%FY 2022: -33.5%FY 2023: -70.7%FY 2024: -16.7%FY 2025: -122.3%
FY 2016 5y median -33.5% FY 2025
ROIC -128.0%
FY 2016: -80.3%FY 2017: -123.2%FY 2018: -33.9%FY 2019: -43.7%FY 2020: -11.9%FY 2021: -12.9%FY 2022: -35.1%FY 2023: -77.1%FY 2024: -97.0%FY 2025: -128.0%
FY 2016 5y median -77.1% FY 2025
ROA -76.9%
FY 2016: -76.9%FY 2017: -110.0%FY 2018: -32.6%FY 2019: -19.7%FY 2020: -6.7%FY 2021: -12.1%FY 2022: -32.5%FY 2023: -64.1%FY 2024: -15.5%FY 2025: -76.9%
FY 2016 5y median -32.5% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 32.6%
FY 2016: -5.3%FY 2017: 20.1%FY 2018: 44.2%FY 2019: -45.4%FY 2020: -13.9%FY 2021: -198.0%FY 2022: -143.5%FY 2023: -32.4%FY 2024: -33.5%FY 2025: 32.6%
FY 2016 FY 2025
EPS (diluted) -28.8%
FY 2016: -6.5%FY 2017: 21.2%FY 2018: 66.5%FY 2019: 55.7%FY 2020: 11.1%FY 2021: -241.7%FY 2022: -131.7%FY 2023: -22.1%FY 2024: 37.1%FY 2025: -28.8%
FY 2016 FY 2025
Free Cash Flow 71.9%
FY 2016: -33.1%FY 2017: 33.1%FY 2018: 42.1%FY 2019: 46.9%FY 2020: -112.6%FY 2021: -873.8%FY 2022: -53.1%FY 2023: -2.8%FY 2024: -42.0%FY 2025: 71.9%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 28.7×FY 2017: 9.4×FY 2018: 39.2×FY 2019: 16.8×FY 2020: 50.4×FY 2021: 19.5×FY 2022: 29.9×FY 2023: 9.1×FY 2024: 11.6×FY 2025: 2.2×
FY 2016 5y median 11.6× FY 2025
Quick Ratio 2.2×
FY 2016: 28.7×FY 2017: 9.4×FY 2018: 39.2×FY 2019: 16.8×FY 2020: 50.4×FY 2021: 19.5×FY 2022: 29.9×FY 2023: 9.1×FY 2024: 11.6×FY 2025: 2.2×
FY 2016 5y median 11.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2016: 1.1×FY 2017: 0.9×FY 2018: 3.0×FY 2019: 2.4×FY 2020: 8.5×FY 2021: 7.3×FY 2022: 2.5×FY 2023: 1.1×FY 2024: 0.9×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31